Gynecomastia happens when the balance between estrogen and testosterone in a male’s body tips toward estrogen. Every male produces some estrogen, but when levels rise too high relative to testosterone, breast gland tissue responds by growing. This isn’t the same as chest fat from weight gain. True gyno involves actual glandular tissue expanding underneath and around the nipple, and it can happen at several points in life for very different reasons.
The Hormonal Shift Behind It
Male breast tissue contains receptors for both estrogen and testosterone. Testosterone keeps breast tissue from growing, while estrogen stimulates it. When the ratio shifts in estrogen’s favor, the ductal tissue, surrounding connective tissue, and stroma begin to proliferate. This is the core mechanism behind every form of gynecomastia, regardless of what triggered the imbalance in the first place.
A key player in this process is an enzyme called aromatase, which converts testosterone into estrogen. Aromatase exists throughout the body, particularly in fat tissue, the liver, and the testes. The adult testes normally produce about 15% of circulating estrogen directly, while the rest is created elsewhere through aromatase converting testosterone and other hormones. Anything that increases aromatase activity or reduces testosterone production can tip the balance.
Puberty Is the Most Common Trigger
Most males first encounter gyno during puberty, typically between ages 10 and 14. During this window, estrogen levels can spike before testosterone production fully catches up. The result is a temporary period where the estrogen-to-androgen ratio favors breast tissue growth. It often shows up as a firm, sometimes tender disc of tissue behind one or both nipples.
For the majority of adolescents, this resolves on its own within six months to two years as testosterone levels rise and stabilize. No treatment is needed in most cases. Persistent gynecomastia that lasts beyond two years or extends past age 17 is less likely to resolve spontaneously and may warrant further evaluation.
It Returns in Older Men
Gynecomastia has a second peak later in life. Somewhere between 24% and 65% of men ages 50 to 80 develop it. Testosterone production naturally declines with age, while body fat tends to increase. Since fat tissue contains aromatase, more fat means more conversion of the remaining testosterone into estrogen. The combination of falling testosterone and rising estrogen makes older men particularly susceptible.
Medications That Cause Gyno
Drugs account for 10% to 25% of all gynecomastia cases, making them one of the most common identifiable causes. Medications can trigger it through several routes: boosting estrogen levels directly, lowering testosterone, blocking testosterone’s effects at the receptor level, or raising prolactin (a hormone that also promotes breast tissue activity).
The medications with the strongest evidence include spironolactone (a blood pressure and fluid retention drug), finasteride and dutasteride (used for hair loss and prostate enlargement), and several drugs used in prostate cancer treatment. Acid reflux medications like omeprazole, certain calcium channel blockers used for blood pressure, opioid painkillers, and the antipsychotic risperidone also carry fair evidence of causing breast tissue growth. If gyno appears after starting a new medication, the timing is usually a strong clue.
Anabolic Steroids and the Aromatization Problem
This is one of the most well-known causes in fitness communities, and the mechanism is straightforward. When someone injects or takes synthetic testosterone or other anabolic steroids, the body is flooded with far more androgens than it naturally produces. Aromatase enzymes throughout the body convert a portion of that excess testosterone into estrogen. The higher the testosterone dose, the more estrogen gets created as a byproduct.
At the same time, the body’s natural testosterone production shuts down in response to the external supply. When a steroid cycle ends, the user can be left with suppressed natural testosterone but lingering elevated estrogen, creating exactly the kind of imbalance that drives breast tissue growth. This is why gyno is a persistent concern among steroid users, and why many attempt to counteract it with estrogen-blocking drugs during or after cycles.
Alcohol, Liver Disease, and Kidney Failure
The liver plays a critical role in breaking down estrogen. When liver function declines, as in cirrhosis, estrogen accumulates in the bloodstream because the liver can no longer clear it efficiently. Alcohol-related liver disease carries a double risk: the liver damage itself allows estrogen to build up, while alcohol directly suppresses testosterone production. Some alcoholic beverages also contain plant-based compounds with weak estrogen-like activity, adding a third layer to the problem.
Chronic kidney failure creates a similar hormonal disruption through a different path. Kidney disease suppresses testosterone production overall and can cause direct damage to the testes. Up to 40% of men with kidney failure also experience malnutrition, which further contributes to hormonal imbalance and breast tissue changes.
Recreational Drugs
Marijuana, heroin, and amphetamines have all been linked to gynecomastia, particularly in adolescents and young adults. Heavy alcohol use outside the context of liver disease can also contribute. The mechanisms vary and, in the case of marijuana, remain somewhat debated. But the association is consistent enough that heavy use of these substances is considered a risk factor worth investigating when gyno appears without another clear explanation.
True Gyno vs. Chest Fat
Not every case of enlarged male breasts involves glandular tissue. Pseudogynecomastia is the term for chest enlargement caused purely by fat deposits, which is common in overweight or obese men. The distinction matters because the causes, progression, and treatment differ significantly.
True gynecomastia produces a firm, rubbery disc of tissue centered behind the nipple. It’s detectable when the tissue exceeds about half a centimeter in diameter. Pseudogynecomastia feels soft and diffuse, without that distinct glandular ridge. One important connection between the two: fat tissue in pseudogynecomastia contains aromatase, so over time, significant fat deposits can increase local estrogen production enough to trigger actual glandular growth, converting pseudogynecomastia into the real thing.
How Gyno Is Treated
Treatment depends entirely on the cause. If a medication is responsible, switching to an alternative often allows the tissue to regress. If an underlying condition like liver or kidney disease is driving the hormone imbalance, addressing that condition is the first step. Pubertal gynecomastia usually just needs time.
For cases that persist, medications that block estrogen’s effect on breast tissue can be effective, particularly when started early. In clinical studies, these drugs produced measurable reduction in breast tissue size in 86% to 91% of patients treated, with a significant proportion seeing their breast nodules shrink by more than half. The earlier treatment begins after tissue starts growing, the better the response tends to be. Once glandular tissue has been present for a long time, it can become fibrotic (scarred and hardened), making it less responsive to medication.
Surgery is the definitive option for long-standing or severe gynecomastia. The typical approach combines liposuction with direct removal of the glandular tissue. Most people return to work within seven to ten days, with low-impact exercise resuming at two to three weeks and full upper-body training at three to six weeks. Strenuous activity is generally off-limits for the first two to three weeks to protect healing.